• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计含氟环丙基取代的 2-苯环丙基甲胺衍生物,鉴定出一种无 5-HT 激动活性的选择性 5-羟色胺 2C(5-HT)受体激动剂。

Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT) receptor agonist without 5-HT agonism.

机构信息

Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, United States.

National Institute of Mental Health Psychoactive Drug Screening Program, and Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, 27599, United States.

出版信息

Eur J Med Chem. 2019 Nov 15;182:111626. doi: 10.1016/j.ejmech.2019.111626. Epub 2019 Aug 14.

DOI:10.1016/j.ejmech.2019.111626
PMID:31445232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6815260/
Abstract

A new series of fluorinated 5-HT agonists were designed and synthesized on the basis of our previous work on 2-phenylcyclopropylmethylamines as a potential approach for the treatment of central nervous system disorders. Key fluorinated cyclopropane moieties were constructed through transition metal catalyzed [2 + 1]-cycloaddition of aromatic vinyl fluorides, and the absolute stereochemistry of the representative compound (-)-21a was established. Functional activity measuring calcium flux at 5-HT receptors reveals high potency for compounds (+)-21a-d. In particular, (+)-21b had no detectable 5-HT agonism and displayed reasonable selectivity against 5-HT. Molecular docking studies were further performed to explain the compounds' possible binding poses to the 5-HT receptor.

摘要

基于我们之前在 2-苯环丙基甲胺作为治疗中枢神经系统疾病的潜在方法方面的工作,设计并合成了一系列新型氟化 5-HT 激动剂。关键的氟化环丙烷部分是通过过渡金属催化的芳基乙烯基氟化物的[2+1]-环加成反应构建的,代表性化合物(-)-21a 的绝对立体化学结构也已确定。通过测量 5-HT 受体的钙流来测定功能活性,结果表明这些化合物具有很高的效力。特别是,(+)-21b 对 5-HT 没有检测到激动作用,并且对 5-HT 具有合理的选择性。进一步进行了分子对接研究,以解释这些化合物与 5-HT 受体可能的结合构象。

相似文献

1
Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT) receptor agonist without 5-HT agonism.设计含氟环丙基取代的 2-苯环丙基甲胺衍生物,鉴定出一种无 5-HT 激动活性的选择性 5-羟色胺 2C(5-HT)受体激动剂。
Eur J Med Chem. 2019 Nov 15;182:111626. doi: 10.1016/j.ejmech.2019.111626. Epub 2019 Aug 14.
2
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.发现N-取代的(2-苯基环丙基)甲胺作为功能选择性5-羟色胺2C受体激动剂,有潜力用作抗精神病药物。
J Med Chem. 2017 Jul 27;60(14):6273-6288. doi: 10.1021/acs.jmedchem.7b00584. Epub 2017 Jul 18.
3
HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia.高通量筛选和合理药物设计以生成一类可能用于精神分裂症治疗的5-羟色胺(2C)选择性配体。
ChemMedChem. 2010 Aug 2;5(8):1221-5. doi: 10.1002/cmdc.201000186.
4
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.2-苯环丙基甲胺类化合物作为选择性 5-羟色胺 2C 受体激动剂的优化及其作为潜在抗精神病药物的评估。
J Med Chem. 2015 Feb 26;58(4):1992-2002. doi: 10.1021/jm5019274. Epub 2015 Feb 10.
5
Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.5-羟色胺2受体亚型的均相高亲和力激动剂结合分析方法的开发。
Assay Drug Dev Technol. 2005 Dec;3(6):649-59. doi: 10.1089/adt.2005.3.649.
6
Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands.双位点 2-苯环丙基甲基胺(PCPMA)衍生物的设计与合成作为选择性多巴胺 D3 受体配体。
J Med Chem. 2020 May 14;63(9):4579-4602. doi: 10.1021/acs.jmedchem.9b01835. Epub 2020 Apr 23.
7
Design and Discovery of Functionally Selective Serotonin 2C (5-HT) Receptor Agonists.设计和发现具有功能选择性的血清素 2C(5-HT)受体激动剂。
J Med Chem. 2016 Nov 10;59(21):9866-9880. doi: 10.1021/acs.jmedchem.6b01194. Epub 2016 Oct 25.
8
Design and synthesis of pyridazinone-based 5-HT(2C) agonists.基于哒嗪酮的5-羟色胺(2C)激动剂的设计与合成。
Bioorg Med Chem Lett. 2009 Oct 1;19(19):5791-5. doi: 10.1016/j.bmcl.2009.07.136. Epub 2009 Aug 6.
9
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.5-羟色胺(5-HT)2A、2B和2C受体激动剂放射性配体结合位点的药理学特性
Naunyn Schmiedebergs Arch Pharmacol. 2004 Aug;370(2):114-23. doi: 10.1007/s00210-004-0951-4. Epub 2004 Jul 30.
10
New halogenated tris-(phenylalkyl)amines as h5-HT2B receptor ligands.新型卤代三(苯基烷基)胺作为5-羟色胺2B受体配体
Bioorg Med Chem Lett. 2016 Jul 15;26(14):3216-3219. doi: 10.1016/j.bmcl.2016.05.079. Epub 2016 May 28.

引用本文的文献

1
Diazepine Agonists of the 5-HT Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352).具有前所未有的选择性的5-羟色胺受体二氮杂䓬类激动剂:贝西卡色林(LP352)的发现。
J Med Chem. 2025 Jun 12;68(11):10599-10618. doi: 10.1021/acs.jmedchem.4c02923. Epub 2025 May 14.
2
Hybrid Metal Catalysts as Valuable Tools in Organic Synthesis: An Overview of the Recent Advances in Asymmetric C─C Bond Formation Reactions.杂化金属催化剂在有机合成中的重要应用:不对称碳-碳键形成反应的最新进展综述
Molecules. 2024 Oct 28;29(21):5090. doi: 10.3390/molecules29215090.
3
Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice.地氯雷他定可改善紫杉醇诱导的小鼠周围神经病变和过敏反应。
Acta Pharmacol Sin. 2024 Oct;45(10):2061-2076. doi: 10.1038/s41401-024-01301-z. Epub 2024 May 24.

本文引用的文献

1
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design.氟原子及含氟基序在药物设计中生物等排体的设计与应用。
J Med Chem. 2018 Jul 26;61(14):5822-5880. doi: 10.1021/acs.jmedchem.7b01788. Epub 2018 Feb 5.
2
5-HT Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.5-HT 受体结构揭示了 G 蛋白偶联受体多效性的结构基础。
Cell. 2018 Feb 8;172(4):719-730.e14. doi: 10.1016/j.cell.2018.01.001. Epub 2018 Feb 1.
3
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.发现N-取代的(2-苯基环丙基)甲胺作为功能选择性5-羟色胺2C受体激动剂,有潜力用作抗精神病药物。
J Med Chem. 2017 Jul 27;60(14):6273-6288. doi: 10.1021/acs.jmedchem.7b00584. Epub 2017 Jul 18.
4
5-HT Agonists Modulate Schizophrenia-Like Behaviors in Mice.5-HT 激动剂调节小鼠的精神分裂样行为。
Neuropsychopharmacology. 2017 Oct;42(11):2163-2177. doi: 10.1038/npp.2017.52. Epub 2017 Mar 15.
5
A short history of the 5-HT receptor: from the choroid plexus to depression, obesity and addiction treatment.5-羟色胺受体简史:从脉络丛到抑郁症、肥胖症及成瘾治疗
Psychopharmacology (Berl). 2017 May;234(9-10):1395-1418. doi: 10.1007/s00213-017-4545-5. Epub 2017 Mar 7.
6
Crystal Structure of an LSD-Bound Human Serotonin Receptor.结合麦角酰二乙胺的人血清素受体的晶体结构
Cell. 2017 Jan 26;168(3):377-389.e12. doi: 10.1016/j.cell.2016.12.033.
7
Design and Discovery of Functionally Selective Serotonin 2C (5-HT) Receptor Agonists.设计和发现具有功能选择性的血清素 2C(5-HT)受体激动剂。
J Med Chem. 2016 Nov 10;59(21):9866-9880. doi: 10.1021/acs.jmedchem.6b01194. Epub 2016 Oct 25.
8
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.含氟药物的下一代,主要制药公司目前处于II-III期临床试验的化合物:新的结构趋势和治疗领域。
Chem Rev. 2016 Jan 27;116(2):422-518. doi: 10.1021/acs.chemrev.5b00392. Epub 2016 Jan 12.
9
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.优化(2-苯基环丙基)甲胺作为新型5-羟色胺2C激动剂的进一步进展:对运动亢进、前脉冲抑制和认知模型的影响
J Med Chem. 2016 Jan 28;59(2):578-91. doi: 10.1021/acs.jmedchem.5b01153. Epub 2016 Jan 13.
10
We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.我们需要2C而非2B:开发用于治疗中枢神经系统疾病的5-羟色胺2C(5-HT2C)受体激动剂
ChemMedChem. 2015 Dec;10(12):1963-7. doi: 10.1002/cmdc.201500437. Epub 2015 Oct 28.